Brink's (BCO) Form 144: 540 Shares Proposed Sale ($62,080)

The Brink's Company (BCO) filer reports a proposed sale of 540 common shares through Merrill Lynch with an aggregate market value of $62,080, scheduled approximately for 08/14/2025.

Rhea-AI Filing Summary

The Brink's Company (BCO) filer reports a proposed sale of 540 common shares through Merrill Lynch with an aggregate market value of $62,080, scheduled approximately for 08/14/2025. The shares were acquired on 05/02/2024 under stock plan activity from the issuer, with payment recorded on the acquisition date. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Small insider sale disclosed; amount is immaterial to company valuation.

The disclosed transaction is a routine sale of 540 shares valued at $62,080, acquired under a company stock plan in May 2024 and proposed to be sold via Merrill Lynch on 08/14/2025. For a publicly traded company of Brink's scale, this size of sale is unlikely to affect market perception or financial metrics. The filing meets Rule 144 disclosure requirements and provides no indication of material operational or financial changes.

Corporate Governance Expert

TL;DR: Compliance filing aligns with Rule 144; contains standard seller representation.

This Form 144 documents a small planned disposition tied to stock plan proceeds and includes the required signer representation about lack of undisclosed material information. There are no related-party concentration issues disclosed and no prior sales reported in the past three months, reducing concerns about aggregated disposition limits or evasive trading. The disclosure appears procedurally complete for the information provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Brink's (BCO) Form 144 disclose?

The filing discloses a proposed sale of 540 common shares through Merrill Lynch valued at $62,080, with an approximate sale date of 08/14/2025.

When were the shares to be sold by BCO acquired?

The shares were acquired on 05/02/2024 under stock plan activity from the issuer, with payment dated the same day.

Has the filer sold other Brink's securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Through which broker will the BCO shares be sold?

The broker listed is Merrill Lynch at the Washington, DC address provided in the filing.

Does the filing indicate any undisclosed material information about Brink's?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2025 - 04:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001852097
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BRINKS CO
SEC File Number	001-09148
Address of Issuer	1801 BAYBERRY COURT P O BOX 18100 RICHMOND VIRGINIA 23226-1800
Phone	804-289-9600
Name of Person for Whose Account the Securities are To Be Sold	Parker Arthelbert Louis
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K St NW, Suite 800 Washington DC 20006	540	62080.00	41662286	08/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2024	Stock plan activity	Issuer			540	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Arthelbert Louis Parker
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)